How many drugs treat Enterobacter Endometritis?

Drug Landscape tracks 3 marketed treatments for Enterobacter Endometritis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/enterobacter-endometritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enterobacter Endometritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enterobacter Endometritis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Enterobacter Endometritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Azactam	AZTREONAM	Bristol-Myers Squibb	Monobactam Antibacterial [EPC]	1986-01-01
Augmentin 250	CLAVULANIC ACID	Dr Reddys Labs Inc	beta Lactamase Inhibitor	1984-01-01
Claforan	CEFOTAXIME	Sterimax	Cephalosporin Antibacterial	1981-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Enterobacter Endometritis
Bristol-Myers Squibb · 1 drug in Enterobacter Endometritis
Dr Reddys Labs Inc · 1 drug in Enterobacter Endometritis
Sterimax · 1 drug in Enterobacter Endometritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Enterobacter Endometritis:

Cite this brief

Drug Landscape (2026). Enterobacter Endometritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/enterobacter-endometritis. Accessed 2026-06-10.

Enterobacter Endometritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing